High Grade Follicular Cell-Derived Non-Anaplastic Thyroid Gland Carcinoma

general

17

Centers

12

Active Trials

$6.1B

Cancer Funding

Specific Cancer Types(2)

NameCenters
Poorly Differentiated Thyroid Gland Carcinoma17
Differentiated High Grade Thyroid Gland Carcinoma—

Top Centers for High Grade Follicular Cell-Derived Non-Anaplastic Thyroid Gland Carcinoma(17)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
Memorial Sloan Kettering Cancer CenterNew York, NY
NCI Comprehensive
—
2
Dana-Farber Cancer InstituteBoston, MA
NCI Comprehensive
—
3
Mayo Clinic Comprehensive Cancer CenterRochester, MN
NCI Comprehensive
—
4
Vanderbilt-Ingram Cancer CenterNashville, TN
NCI Comprehensive
—
5
UC San Diego Moores Cancer CenterLa Jolla, CA
NCI Comprehensive
—
6
Duke Cancer InstituteDurham, NC
NCI Comprehensive
—
7
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH
NCI Comprehensive
—
8
City of Hope Comprehensive Cancer CenterDuarte, CA
NCI Comprehensive
—
9
USC Norris Comprehensive Cancer CenterLos Angeles, CA
NCI Comprehensive
—
10
University of Colorado Cancer CenterAurora, CO
NCI Comprehensive
—
11
Moffitt Cancer CenterTampa, FL
NCI Comprehensive
—
12
Huntsman Cancer Institute at the University of UtahSalt Lake City, UT
NCI Comprehensive
—
13
The University of Kansas Cancer CenterKansas City, KS
NCI Comprehensive
—
14
University of Illinois Cancer CenterChicago, IL
—
15
Boston University Cancer CenterBoston, MA
—
16
Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL
—
17
Tampa General Hospital Cancer InstituteTampa, FL
—

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →